https://idwiki.org/index.php?action=history&feed=atom&title=CR%3ADOI%3Ac8979d6d33702fc9854f30445fad20d0 2026-04-08T20:11:47Z Revision history for this page on the wiki MediaWiki 1.43.6 https://idwiki.org/index.php?title=CR:DOI:c8979d6d33702fc9854f30445fad20d0&diff=11685&oldid=prev 2026-04-08T14:54:28Z

<p>Created page with &quot;{{#scite: |reference=guery2018ex |type=journal-article |title=Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial |author=Benoit Guery;Francesco Menichetti;Veli-Jukka Anttila;Nicholas Adomakoh;Jose Maria Aguado;Karen Bisnauthsing;Areti Georgopali;Simon D Goldenberg;Andreas Karas;Gbenga Kazeem;Chris Longshaw;Jose Alejandro Palacios-Fabrega;Oliv...&quot;</p> <p><b>New page</b></p><div>{{#scite:<br /> |reference=guery2018ex<br /> |type=journal-article<br /> |title=Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial<br /> |author=Benoit Guery;Francesco Menichetti;Veli-Jukka Anttila;Nicholas Adomakoh;Jose Maria Aguado;Karen Bisnauthsing;Areti Georgopali;Simon D Goldenberg;Andreas Karas;Gbenga Kazeem;Chris Longshaw;Jose Alejandro Palacios-Fabrega;Oliver A Cornely;Maria J G T Vehreschild|+sep=;<br /> |journal=The Lancet Infectious Diseases<br /> |publisher=Elsevier BV<br /> |year=2018<br /> |volume=18<br /> |issue=3<br /> |pages=296-307<br /> |doi=10.1016/s1473-3099(17)30751-x<br /> |issn=1473-3099<br /> |retrieved-from=https://dx.doi.org/<br /> |retrieved-on=2026-04-08<br /> |@show=true<br /> }}</div>

Aidan